<ARTICLE> 5 <LEGEND> This schedule contains summary information extracted from Intel Corporation's CONSOLIDATED CONDENSED STATEMENTS OF INCOME and CONSOLIDATED CONDENSED BALANCE SHEETS and is qualified in its entirety by reference to such financial statements. </LEGEND> <MULTIPLIER> 1,000,000 <PERIOD-TYPE> 9-MOS <FISCAL-YEAR-END> DEC-27-1997 <PERIOD-END> SEP-27-1997 <CASH> 4985 <SECURITIES> 3975 <RECEIVABLES> 3921<F3> <ALLOWANCES> 0 <INVENTORY> 1507 <CURRENT-ASSETS> 15140 <PP&E> 16812 <DEPRECIATION> 7067 <TOTAL-ASSETS> 27201 <CURRENT-LIABILITIES> 5164 <BONDS> 386 <PREFERRED-MANDATORY> 582<F1> <PREFERRED> 0 <COMMON> 3389 <OTHER-SE> 16557 <TOTAL-LIABILITY-AND-EQUITY> 27201 <SALES> 18563 <TOTAL-REVENUES> 18563 <CGS> 7254 <TOTAL-COSTS> 7254 <OTHER-EXPENSES> 1742<F2> <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 20 <INCOME-PRETAX> 8065 <INCOME-TAX> 2863 <INCOME-CONTINUING> 5202 <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> 5202 <EPS-PRIMARY> 2.89 <EPS-DILUTED> 0<F4> <FN> <F1> Item consists of put warrants. <F2> Item consists of research and development. <F3> Item shown net of allowance, consistent with the balance sheet presentation. <F4> Item not reported because immaterially different from primary EPS. </FN>